Genocea Biosciences Inc expected to post a loss of 20  cents a share - Earnings Preview

Genocea Biosciences

07/02/2022 14:49

* Genocea Biosciences Inc  GNCA.OQ   GNCA.O  is expected
to show
no change in quarterly revenue when it reports  results on
February 9 (estimated). 
    * ​Refinitiv's mean analyst estimate for Genocea Biosciences
Inc
is for a loss of 20 cents per share. For the same quarter last
year, the company reported a loss of 23 cents per share.
    * The current average analyst rating on the shares is
"strong buy"
and the breakdown of recommendations is 4 "strong buy" or
"buy," no "hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Genocea
Biosciences Inc is $6​, about 83.2% above​ its last closing
price of $1.01. ​​​
    * 

This summary was machine generated February 7 at 14:49 GMT.  All
figures in US dollars  unless otherwise stated